resiquimod has been researched along with apilimod in 2 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (apilimod) | Trials (apilimod) | Recent Studies (post-2010) (apilimod) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 32 | 4 | 25 |
| Protein | Taxonomy | resiquimod (IC50) | apilimod (IC50) |
|---|---|---|---|
| 1-phosphatidylinositol 3-phosphate 5-kinase | Homo sapiens (human) | 0.0078 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Cai, X; Huang, Q; Kim, YM; Loureiro, J; Xu, Y | 1 |
2 other study(ies) available for resiquimod and apilimod
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3.
Topics: Activating Transcription Factor 3; Animals; Cell Line; Cell Line, Tumor; HEK293 Cells; Humans; Hydrazones; Imidazoles; Immunoblotting; Interferon Type I; Luminescent Proteins; Macrophages; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Morpholines; Oligonucleotide Array Sequence Analysis; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Protein Binding; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Toll-Like Receptors; Transcriptome; Triazines | 2014 |